Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BPH GLOBAL LTD Regulatory Filings 2021

Mar 28, 2021

64553_rns_2021-03-28_a907f40b-15f5-4300-944c-93597a2e0b86.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

==> picture [99 x 61] intentionally omitted <==

STEMCELL UNITED LIMITED ACN 009 104 330

Level 12, 680 George Street, Sydney, NSW 2000, Australia

29 March 2021

Australian Securities Exchange

Updates to un-reviewed half year accounts

With reference to the announcement of 26 February 2021 “Extension to lodge reviewed December 2020 half year report”, Stemcell United Limited (ASX:SCU) (“Company”) would like to advise on the updated un-reviewed Consolidated Statement Of Comprehensive Income and Consolidated Statement Of Financial Position as a result of material differences due to impairment of assets and reclassification of accounts.

The material differences to the accounts, resulting from the impairment of assets and reclassification of accounts, are highlighted in yellow in the following update un-reviewed Consolidated Statement of Comprehensive Income and Consolidated Statement Of Financial Position.

The Company will immediately make further announcement to the market if there is any new material difference between this un-reviewed half year accounts and its reviewed half year accounts.

This announcement has been authorised for release by the Board of Stemcell United Limited.

End

STEMCELL UNITED LIMITED AND ITS CONTROLLED ENTITIES

UPDATED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE HALF-YEAR ENDED 31 DECEMBER 2020

Half year
31 Dec 2020
$
Revenue from sale of goods 3,697,404
Cost of sales (3,265,474)
Gross profit 431,930
Other income 16,801
Administrative expenses (1,772,192)
Loss before income tax expense (1,323,461)
Income tax credit -
Loss for the half-year (1,323,461)
Other comprehensive income/(loss) for the period
Items that may be reclassified to profit or loss:
Translation of foreign subsidiary (111,078)
Total comprehensive loss for the period (1,434,539)
Loss attributable to:
Owners (1,416,660)
Non-controlling interest 93,199
(1,323,461)
Total comprehensive loss attributable to:
Owners (1,527,738)
Non-controlling interest 93,199
(1,434,539)
Earnings Per Share
Basic loss per share (cents per share) (0.20)
Diluted loss per share (cents per share) (0.20)
Earnings Per Share attributable to owners
Basic loss per share (cents per share) (0.21)
Diluted loss per share (cents per share) (0.21)

Material differences highlighted in yellow.

STEMCELL UNITED LIMITED AND ITS CONTROLLED ENTITIES

UPDATED CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2020

A A A
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Trade and other receivables
It
Note s at
31 D 2020
ec
$
3 2,010,443
848,164
861369
nvenory
TOTAL CURRENT ASSETS
,
3,719,976
NON CURRENT ASSETS
Property plant and equipment
Right of Use
Intangible assets
Investment in associates
TOTAL NON CURRENT ASSETS
TOTAL ASSETS
LIABILITIES
CURRENT LIABILITIES
Trade and other payables
10
4
142,147
551,729
1

1
693,878
4,413,854
1,312,716

Short term borrowings
TOTAL CURRENT LIABILITIES
TOTAL LIABILITIES
NET ASSETS
EQUITY
Issued capital
Option reserve
Accumulated losses
Foreign exchange translation reserve
EQUITY ATTRIBUTABLE TO SHAREHOLDERS
Non-controlling interest
TOTAL EQUITY
5
6
736,300
2,049,016
2,049,016
2,364,838
73,751,629
912,600
(73,018,972)
(14,356)
1,617,507
747,331
2,364,838

Material differences highlighted in yellow.